Cooley LLP advised Molecular Templates on the deal.Clinical-stage biopharmaceutical company Molecular Templates (MTEM) announced its strategic research collaboration with Bristol Myers Squibb to discover and develop therapies…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
